The Healthtech Times is a weekly newsletter covering healthtech news from Canada and around the globe. Subscribe to H|T using the form at the bottom of this page to ensure you don’t miss out on the most important healthtech news every week!
Canada has announced the launch of its national COVID-19 “exposure notification” app. The app is now available through Apple and Google app stores.
The U.S. National Institutes of Health (NIH) is revealing the first beneficiaries of its Rapid Acceleration of Diagnostics (RADx) program, and San Mateo-based Helix is on the receiving end of $33 million in federal funding as a result.
One year into the CAN Health Network, a project meant to streamline the healthcare procurement process, Minister Ng says there could be potential to expand.
Vancouver COVID-19 therapy developer AbCellera eyeing potential IPO as early as fall (THE GLOBE AND MAIL)
The biotechnology startup is set to decide in the next two weeks whether to start a process to go public, CEO Carl Hansen says.
Toronto-based telehealth startup Dialogue has raised $43 million CAD led by Canadian life insurance company Sun Life Financial.
Ottawa health-tech startup draws on VR technology to make surgeons’ jobs easier (OTTAWA BUSINESS JOURNAL)
Realize Medical’s system, dubbed Elucis, allows medical engineers to “draw” complex 3D images such as the inner workings of a patient’s knee in a VR environment.
Ottawa-based L-Spark has opened applications for a new MedTech accelerator program with Telus.
Withings has raised $60 million in venture capital as the connected health company, primarily known for its consumer gadgets, expands its focus to include business customers.
eSight has launched the newest iteration of its glasses designed to enhance vision for those living with eye disease and disorders, and legal blindness.
Expanding telehealth during a pandemic: how 4 health systems did it (HEALTHTECH MAGAZINE)
Faced with unprecedented challenges, hospitals leverage a variety of tools and strategies to meet a vast need for virtual care.